Status: open
Endo; Teikoku; Watson (Lidoderm)
Defendant: Endo; Teikoku; Watson
Consumers who bought certain dosages of Lidoderm and/or its generic version between August 23, 2012 and August 1, 2014 may be eligible for payment. The companies reached a settlement over allegations of antitrust violations.